期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
The Impact of Double-puncture Tympanic Membrane Puncture and Tympanic Cavity Drug Injection on the Complication Rate of Acute Secretory Otitis Media
1
作者 Wei Zheng 《Proceedings of Anticancer Research》 2026年第1期54-60,共7页
Objective:To explore the therapeutic effect of double-puncture tympanic membrane puncture and tympanic cavity drug injection in patients with acute secretory otitis media.Methods:A total of 84 patients with acute secr... Objective:To explore the therapeutic effect of double-puncture tympanic membrane puncture and tympanic cavity drug injection in patients with acute secretory otitis media.Methods:A total of 84 patients with acute secretory otitis media admitted to our hospital from June 2024 to June 2025 were selected and randomly divided into two groups by drawing lots.The control group(42 cases)was treated with the traditional single-puncture tympanic membrane puncture and tympanic cavity drug injection method,while the observation group(42 cases)was treated with the double-puncture tympanic membrane puncture and tympanic cavity drug injection method.The therapeutic effects of the two groups were compared.Results:The overall treatment response rate,overall complication rate,time to symptom relief,and improvement in hearing threshold in the observation group were all superior to those in the control group,with statistically significant differences(P<0.05).Conclusion:For acute secretory otitis media,the treatment method of double-puncture tympanic membrane puncture and tympanic cavity drug injection demonstrates definite efficacy,significantly reducing the incidence of complications,accelerating symptom relief,and improving hearing function,making it worthy of promotion. 展开更多
关键词 Acute secretory otitis media Double puncture tympanic membrane puncture and tympanic cavity drug injection COMPLICATIONS
暂未订购
Clinical Analysis of Tympanesis Combined with Dexamethasone Tympanum Injection in the Treatment of Secretory Otitis Media
2
作者 MAIMAITIAILI Tusong 《外文科技期刊数据库(文摘版)医药卫生》 2021年第9期1139-1141,共5页
Objective: to analyze the effect of dexamethasone combined with tympanesis in the treatment of secretory otitis media. Methods: July 2020 to July 2021 of our hospital to receive 64 cases of secretory otitis media pati... Objective: to analyze the effect of dexamethasone combined with tympanesis in the treatment of secretory otitis media. Methods: July 2020 to July 2021 of our hospital to receive 64 cases of secretory otitis media patients, the patients and patients families and informed consent as a research object, the control group patients with tympanic membrane puncture therapy, observation group of patients on the basis of tympanic membrane puncture treatment also need to adopt the way of dex tympanic cavity injection treatment. Results: the incidence of external auditory canal suppuration and abscess in the observation group was lower than that in the control group, and the treatment efficiency of the observation group was higher than that of the control group after treatment. Conclusion: in the treatment of patients with secretory otitis media, tympanum injection of dexamethasone combined with tympanemesis has a significant therapeutic effect, which can ensure the safety of treatment and reduce the probability of adverse reactions in patients on the basis of improving the effective rate of treatment. 展开更多
关键词 tympanic membrane puncture tympanic injection of dexamethasone TREATMENT secretory otitis media
暂未订购
激素不同给药途径治疗突发性聋疗效观察 被引量:2
3
作者 张晓红 鄢胜刚 高宇阳 《中国耳鼻咽喉头颈外科》 CSCD 2024年第11期742-744,共3页
目的观察激素不同给药途径治疗突发性聋的疗效。方法回顾性分析海宁市中医院2021年4月~2024年4月间90例(90耳)突发性聋患者的病历资料,根据糖皮质激素用药方案分为静脉注射组26例(26耳)、鼓室注射组31例(31耳)、耳后注射组33例(33耳),... 目的观察激素不同给药途径治疗突发性聋的疗效。方法回顾性分析海宁市中医院2021年4月~2024年4月间90例(90耳)突发性聋患者的病历资料,根据糖皮质激素用药方案分为静脉注射组26例(26耳)、鼓室注射组31例(31耳)、耳后注射组33例(33耳),均予以营养神经甲钴胺及认知行为疗法,此外分别予以地塞米松磷酸钠注射液静脉注射、经鼓膜穿刺注射、耳后注射,比较三组治疗疗效及治疗前后平均纯音听阈值(PTA)、主观症状视觉模拟量表(VAS)评分及不良反应。结果静脉注射组痊愈、显效、有效、无效分别为4例(15.38%)、6例(23.08%)、7例(26.92%)、9例(34.62%),鼓室注射组分别为14例(45.16%)、8例(25.81%)、4例(12.90%)、5例(16.13%),耳后注射组分别为21例(63.64%)、9例(27.27%)、2例(6.06%)、1例(3.03%)。总有效率比较,耳后注射组高于静脉注射组(P<0.05),静脉注射组与鼓室注射组、鼓室注射组与耳后注射组比较,差异均无统计意义(P>0.05);总显效率比较,鼓室注射组、耳后注射组均高于静脉注射组(P<0.05),且耳后注射组高于鼓室注射组(P<0.05);三组患者治疗后PTA及耳鸣、耳闷感VAS评分均较治疗前下降,且鼓室注射组、耳后注射组均低于静脉注射组,耳后注射组低于鼓室注射组,差异均有统计学意义(P<0.05);三组治疗期间均未见严重的全身不良反应,静脉注射组出现5例胃肠道不适,3例血小板增加,总发生率30.77%,鼓室注射组、耳后注射组仅出现局部不良反应,其中鼓室注射组治疗期间出现眩晕10例次,出血1例次,耳鸣2例次,不良反应总发生率41.94%,耳后注射组出现眩晕2例次,出血2例次,耳鸣1例次,不良反应总发生率15.15%,鼓室注射组不良反应总发生率高于耳后注射组(P<0.05)。结论耳后注射治疗突发性聋总显效率更高,治疗后听力及耳鸣、耳闷感改善均优于静脉注射和鼓室注射,且不良反应发生率显著低于鼓室注射,提示耳后注射途径在疗效和安全性方面具有优势。 展开更多
关键词 耳聋(Deafness) 糖皮质激素类(Glucocorticoids) 投药途径(Drug Administration Routes) 注射 静脉内(injections Intravenous) 鼓室注射(injection of tympanic cavity) 耳后注射(postauricular injection)
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部